Docosahexaenoic acid (22:6n-3) is the major brain n-3 polyunsaturated fatty acid and it is possible that docosahexaenoic acid is anti-inflammatory in the brain as it is known to be in other tissues. Using a combination of models including the fat-1 transgenic mouse, chronic dietary n-3 polyunsaturated fatty acid modulation in transgenic and wild-type mice, and acute direct brain infusion, we demonstrated that unesterified docosahexaenoic acid attenuates neuroinflammation initiated by intracerebroventricular lipopolysaccharide. Hippocampal neuroinflammation was assessed by gene expression and immunohistochemistry. Furthermore, docosahexaenoic acid protected against lipopolysaccharide-induced neuronal loss. Acute intracerebroventricular infusion of unesterified docosahexaenoic acid or its 12/15-lipoxygenase product and precursor to protectins and resolvins, 17S-hydroperoxy-docosahexaenoic acid, mimics anti-neuroinflammatory aspects of chronically increased unesterified docosahexaenoic acid. LC-MS/MS revealed that neuroprotectin D1 and several other docosahexaenoic acid-derived specialized pro-resolving mediators are present in the hippocampus. Acute intracerebroventricular infusion of 17S-hydroperoxy-docosahexaenoic acid increases hippocampal neuroprotectin D1 levels concomitant to attenuating neuroinflammation. These results show that unesterified docosahexaenoic acid is protective in a lipopolysaccharide-initiated mouse model of acute neuroinflammation, at least in part, via its conversion to specialized pro-resolving mediators; these docosahexaenoic acid stores may provide novel targets for the prevention and treatment(s) of neurological disorders with a neuroinflammatory component. Our study shows that chronically increased brain unesterified DHA levels, but not solely phospholipid DHA levels, attenuate neuroinflammation. Similar attenuations occur with acute increases in brain unesterified DHA or 17S-HpDHA levels, highlighting the importance of an available pool of precursor unesterified DHA for the production of enzymatically derived specialized pro-resolving mediators that are critical in the regulation of neuroinflammation.
n class="Chemical">Docosahexaenoic acid (22:6npan>-3) is the major brainpan> pan> class="Chemical">n-3 polyunsaturated fatty acid and it is possible that docosahexaenoic acid is anti-inflammatory in the brain as it is known to be in other tissues. Using a combination of models including the fat-1 transgenic mouse, chronic dietary n-3 polyunsaturated fatty acid modulation in transgenic and wild-type mice, and acute direct brain infusion, we demonstrated that unesterified docosahexaenoic acid attenuates neuroinflammation initiated by intracerebroventricular lipopolysaccharide. Hippocampal neuroinflammation was assessed by gene expression and immunohistochemistry. Furthermore, docosahexaenoic acid protected against lipopolysaccharide-induced neuronal loss. Acute intracerebroventricular infusion of unesterified docosahexaenoic acid or its 12/15-lipoxygenase product and precursor to protectins and resolvins, 17S-hydroperoxy-docosahexaenoic acid, mimics anti-neuroinflammatory aspects of chronically increased unesterified docosahexaenoic acid. LC-MS/MS revealed that neuroprotectin D1 and several other docosahexaenoic acid-derived specialized pro-resolving mediators are present in the hippocampus. Acute intracerebroventricular infusion of 17S-hydroperoxy-docosahexaenoic acid increases hippocampal neuroprotectin D1 levels concomitant to attenuating neuroinflammation. These results show that unesterified docosahexaenoic acid is protective in a lipopolysaccharide-initiated mouse model of acute neuroinflammation, at least in part, via its conversion to specialized pro-resolving mediators; these docosahexaenoic acid stores may provide novel targets for the prevention and treatment(s) of neurological disorders with a neuroinflammatory component. Our study shows that chronically increased brain unesterified DHA levels, but not solely phospholipidDHA levels, attenuate neuroinflammation. Similar attenuations occur with acute increases in brain unesterified DHA or 17S-HpDHA levels, highlighting the importance of an available pool of precursor unesterified DHA for the production of enzymatically derived specialized pro-resolving mediators that are critical in the regulation of neuroinflammation.
Authors: Kristopher G Sheets; Yongdong Zhou; Monica K Ertel; Eric J Knott; Cornelius E Regan; Jasmine R Elison; William C Gordon; Per Gjorstrup; Nicolas G Bazan Journal: Mol Vis Date: 2010-03-02 Impact factor: 2.367
Authors: Dennis R Hoffman; Julia A Boettcher; Deborah A Diersen-Schade Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2009-06-07 Impact factor: 4.006
Authors: Mikhail Y Golovko; Gwendolyn Barceló-Coblijn; Paula I Castagnet; Susan Austin; Colin K Combs; Eric J Murphy Journal: Mol Cell Biochem Date: 2008-12-31 Impact factor: 3.396
Authors: Matthew Spite; Lucy V Norling; Lisa Summers; Rong Yang; Dianne Cooper; Nicos A Petasis; Roderick J Flower; Mauro Perretti; Charles N Serhan Journal: Nature Date: 2009-10-29 Impact factor: 49.962
Authors: Ameer Y Taha; Yewon Cheon; Keturah F Faurot; Beth Macintosh; Sharon F Majchrzak-Hong; J Douglas Mann; Joseph R Hibbeln; Amit Ringel; Christopher E Ramsden Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2014-02-24 Impact factor: 4.006
Authors: Yurika Otoki; Adam H Metherel; Theresa Pedersen; Jun Yang; Bruce D Hammock; Richard P Bazinet; John W Newman; Ameer Y Taha Journal: Lipids Date: 2019-11-06 Impact factor: 1.880
Authors: Lin Lin; Adam H Metherel; Mathieu Di Miceli; Zhen Liu; Cigdem Sahin; Xavier Fioramonti; Carolyn L Cummins; Sophie Layé; Richard P Bazinet Journal: J Lipid Res Date: 2020-08-21 Impact factor: 5.922
Authors: Grace Y Sun; Dennis Y Chuang; Yijia Zong; Jinghua Jiang; James C M Lee; Zezong Gu; Agnes Simonyi Journal: Mol Neurobiol Date: 2014-02-27 Impact factor: 5.590